Marcin Renke

Marcin Renke

Auto-generated profile, based on publicly available information

Marcin Renke

Department of Occupational, Metabolic and Internal Diseases, Medical University of Gdansk, 81-519 Gdynia, Poland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
Leszek TylickiLeszek Tylicki
Leszek Tylicki
PRPrzemysław Rutkowski
Przemysław Rutkowski
MRMarcin Renke
Marcin Renke
WLWojciech Larczyński
Wojciech Larczyński
EAEwa Aleksandrowicz
Ewa Aleksandrowicz
BRBolesław Rutkowski
Bolesław Rutkowski

11 November 2010 in Kidney and Blood Pressure Research
Verified
Journal Article
Open access
PDF file
AKAgnieszka Kuchta
Agnieszka Kuchta
APAnastasis Pacanis
Anastasis Pacanis
BKBarbara Kortas-Stempak
Barbara Kortas-Stempak
AÇAgnieszka Çwiklińska
Agnieszka Çwiklińska
MZMarcin Ziętkiewicz
Marcin Ziętkiewicz
BRBoleslaw Rutkowski
Boleslaw Rutkowski
Changes mediated by oxidative stress are thought to be involved with atherosclerosis in patients with chronic kidney disease (CKD). The purpose of this study was to analyze the markers of oxidative damage and the activity of antioxidative enzymes as well as the total antioxidant capability in patients with different stages of CKD, both conventionally treated and dialyzed. We evaluated the oxidative modification of lipids (by oxidized low-density lipoprotein and malonodialdehyde levels) and proteins (by advanced oxidation protein products level). We also assessed the activity of paraoxonase-1 and glutathione peroxidases and total antioxidant status. Compared with the control group, the uremic patients, both dialyzed and nondialyzed, had higher levels of all studied plasma oxidative stress markers and decreased activity of antioxidative enzymes. Our results lead us to conclude that oxidative stress seems to be related rather to the uremic state than to the dialysis treatment. We also showed that estimating total antioxidant status in a simple test is unreliable for assessing the antioxidant ability of patients with CKD.

28 June 2020 in Medicina
Verified
Journal Article
Open access
PDF file
EBEmilia Błeszyńska
Emilia Błeszyńska
ŁWŁukasz Wierucki
Łukasz Wierucki
TZTomasz Zdrojewski
Tomasz Zdrojewski
MRMarcin Renke
Marcin Renke
Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect drug combinations. Since many years patient safety during the treatment process has been one of key elements for proper functioning of healthcare systems around the world, thus different preventive measures have been undertaken in order to counteract factors adversely affecting the therapeutic effect. One of the avoidable medical errors is pharmacological interactions. According to estimates, one in six elderly patients may be at risk of a significant drug interaction. Hence the knowledge about mechanisms and causes of drug interactions in the elderly, as well as consequences of their occurrence are crucial for planning the process of pharmacotherapy. For the purpose of pharmacovigilance, a review of available methods and tools gives an insight into possible ways of preventing drug interactions. Additionally, recognizing the actual scale of this phenomenon in geriatric population around the world emphasizes the importance of a joint effort among medical community to improve quality of pharmacotherapy.

Verified
Journal Article
Open access
PDF file
WWWojciech Wołyniec
Wojciech Wołyniec
WRWojciech Ratkowski
Wojciech Ratkowski
JRJoanna Renke
Joanna Renke
MRMarcin Renke
Marcin Renke
More than 100 substances have been identified as biomarkers of acute kidney injury. These markers can help to diagnose acute kidney injury (AKI) in its early phase, when the creatinine level is not increased. The two markers most frequently studied in plasma and serum are cystatin C and neutrophil gelatinase-associated lipocalin (NGAL). The former is a marker of kidney function and the latter is a marker of kidney damage. Some other promising serum markers, such as osteopontin and netrin-1, have also been proposed and studied. The list of promising urinary markers is much longer and includes cystatin C, NGAL, kidney injury molecule-1 (KIM-1), liver-type fatty-acid-binding protein (L-FABP), interleukin 18, insulin-like growth factor binding protein 7 (IGFBP-7), tissue inhibitor of metalloproteinases-2 (TIMP-2) and many others. Although these markers are increased in urine for no longer than a few hours after nephrotoxic agent action, they are not widely used in clinical practice. Only combined IGFBP-7/TIMP-2 measurement was approved in some countries as a marker of AKI. Several studies have shown that the levels of urinary AKI biomarkers are increased after physical exercise. This systematic review focuses on studies concerning changes in new AKI biomarkers in healthy adults after single exercise. Twenty-seven papers were identified and analyzed in this review. The interpretation of results from different studies was difficult because of the variety of study groups, designs and methodology. The most convincing data concern cystatin C. There is evidence that cystatin C is a better indicator of glomerular filtration rate (GFR) in athletes after exercise than creatinine and also at rest in athletes with a lean mass lower or higher than average. Serum and plasma NGAL are increased after prolonged exercise, but the level also depends on inflammation and hypoxia; therefore, it seems that in physical exercise, it is too sensitive for AKI diagnosis. It may, however, help to diagnose subclinical kidney injury, e.g., in rhabdomyolysis. Urinary biomarkers are increased after many types of exercise. Increases in NGAL, KIM-1, cystatin-C, L-FABP and interleukin 18 are common, but the levels of most urinary AKI biomarkers decrease rapidly after exercise. The importance of this short-term increase in AKI biomarkers after exercise is doubtful. It is not clear if it is a sign of mild kidney injury or physiological metabolic adaptation to exercise.

12 October 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
Alicja Dębska-ŚlizieńAlicja Dębska-Ślizień
Alicja Dębska-Ślizień
ZŚZuzanna Ślizień
Zuzanna Ślizień
MMMarta Muchlado
Marta Muchlado
AKAlicja Kubanek
Alicja Kubanek
MPMagdalena Piotrowska
Magdalena Piotrowska
Leszek TylickiLeszek Tylicki
Leszek Tylicki
Background: The efficacy of SARS-CoV-2 vaccination among kidney transplant recipients (KTR) is low. The main goal of this study was to analyze factors that may influence the humoral response to vaccination. Methods: We analyzed the titer magnitude of IgG antibodies directed against spike (S)-SARS-CoV-2 antigen after the second dose of the mRNA vaccine in 142 infection naïve KTR (83 men, i.e., 58.4%) with a median age (IQR) of 54 (41–63), and 36 respective controls without chronic kidney disease. mRNA-1273 or BNT162b2 were applied in 26% and 74% of KTR, respectively. Results: S-specific immune response (seroconversion) was seen in 73 (51.41%) of KTR, and in all controls 36 (100%). Independent predictors of no response were elder age, shorter transplantation vintage, and a more than two-drug immunosuppressive protocol. In subgroup analyses, the seroconversion rate was highest among KTR without MMF/MPS treatment (70%), treated with no more than two immunosuppressants (69.2%), treated without corticosteroid (66.7%), younger patients aged <54 years (63.2%), and those vaccinated with the mRNA-1273 vaccine (62.16%). The independent predictors of higher S-antibody titer among responders were younger age, treatment with no more than two immunosuppressants, and the mRNA-1273 vaccination. Conclusions: Our study confirmed a low rate of seroconversion after vaccination with the mRNA vaccine in KTR. The major modifiable determinants of humoral response were the composition of the immunosuppressive protocol, as well as the type of vaccine. The latter could be taken into consideration when initial vaccination as well as booster vaccination is considered in KTR.

1 February 2004 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
PRPrzemysław Rutkowski
Przemysław Rutkowski
Leszek TylickiLeszek Tylicki
Leszek Tylicki
MRMarcin Renke
Marcin Renke
GKGrzegorz Korejwo
Grzegorz Korejwo
ZZZbigniew Zdrojewski
Zbigniew Zdrojewski
BRBoleslaw Rutkowski
Boleslaw Rutkowski